135 related articles for article (PubMed ID: 21809665)
21. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type.
al-Saleh W; Delvenne P; Greimers R; Fridman V; Doyen J; Boniver J
Am J Clin Pathol; 1995 Aug; 104(2):154-60. PubMed ID: 7639189
[TBL] [Abstract][Full Text] [Related]
22. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
[TBL] [Abstract][Full Text] [Related]
23. Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia.
Kruse AJ; Baak JP; de Bruin PC; van de Goot FR; Kurten N
J Pathol; 2001 Dec; 195(5):557-62. PubMed ID: 11745691
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of p73alpha in normal ectocervical epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma.
Nenutil R; Ceskova P; Coates PJ; Nylander K; Vojtesek B
Int J Gynecol Pathol; 2003 Oct; 22(4):386-92. PubMed ID: 14501821
[TBL] [Abstract][Full Text] [Related]
25. Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium.
Lindström AK; Asplund A; Hellberg D
Gynecol Oncol; 2011 Aug; 122(2):372-6. PubMed ID: 21632100
[TBL] [Abstract][Full Text] [Related]
26. Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer.
Zhou JH; Chen HZ; Ye F; Lu WG; Xie X
Oncol Rep; 2006 Aug; 16(2):307-11. PubMed ID: 16820908
[TBL] [Abstract][Full Text] [Related]
27. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix.
Chen G; He C; Li L; Lin A; Zheng X; He E; Skog S
BMC Cancer; 2013 May; 13():249. PubMed ID: 23693054
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia.
Lee JS; Kim HS; Jung JJ; Lee MC; Park CS
Anal Quant Cytol Histol; 2002 Apr; 24(2):103-13. PubMed ID: 12026048
[TBL] [Abstract][Full Text] [Related]
30. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the inmunohistochemical markers PCNA and MIB-1 in the diagnosis of low grade lesions of the uterine cervix].
Sánchez-Rosales M; Osorio-Morales S; Díaz-Araujo F
Invest Clin; 2004 Sep; 45(3):213-20. PubMed ID: 15469067
[TBL] [Abstract][Full Text] [Related]
32. Tenascin expression in intraepithelial neoplasia and invasive carcinoma of the uterine cervix.
Iskaros BF; Koss LG
Arch Pathol Lab Med; 2000 Sep; 124(9):1282-6. PubMed ID: 10975921
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
Celewicz A; Celewicz M; Wężowska M; Chudecka-Głaz A; Menkiszak J; Urasińska E
Pol J Pathol; 2018; 69(1):42-47. PubMed ID: 29895125
[TBL] [Abstract][Full Text] [Related]
34. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables.
Kruse AJ; Baak JP; Janssen EA; Bol MG; Kjellevold KH; Fianne B; Lovslett K; Bergh J
J Pathol; 2003 Apr; 199(4):462-70. PubMed ID: 12635137
[TBL] [Abstract][Full Text] [Related]
35. A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix.
Carreras R; Alameda F; Mancebo G; García-Moreno P; Mariñoso ML; Costa C; Fusté P; Baró T; Serrano S
Histol Histopathol; 2007 Jun; 22(6):587-92. PubMed ID: 17357088
[TBL] [Abstract][Full Text] [Related]
36. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
37. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix.
Bandiera A; Bonifacio D; Manfioletti G; Mantovani F; Rustighi A; Zanconati F; Fusco A; Di Bonito L; Giancotti V
Cancer Res; 1998 Feb; 58(3):426-31. PubMed ID: 9458084
[TBL] [Abstract][Full Text] [Related]
38. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia.
Resnick M; Lester S; Tate JE; Sheets EE; Sparks C; Crum CP
Hum Pathol; 1996 Mar; 27(3):234-9. PubMed ID: 8600036
[TBL] [Abstract][Full Text] [Related]
39. Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma.
Gaiotto MA; Focchi J; Ribalta JL; Stávale JN; Baracat EC; Lima GR; Guerreiro da Silva ID
Am J Obstet Gynecol; 2004 May; 190(5):1278-82. PubMed ID: 15167830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
